Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways. [electronic resource]
Producer: 20200410Description: 122 p. digitalISSN:- 1479-5876
- Animals
- Apoptosis -- drug effects
- Diet, Protein-Restricted
- Dietary Supplements
- Disease Progression
- Female
- Humans
- Inflammation -- pathology
- Keto Acids -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Male
- Mice, Inbred C57BL
- Middle Aged
- NF-kappa B -- metabolism
- Probability
- Renal Insufficiency, Chronic -- drug therapy
- Reperfusion Injury -- complications
- Survival Analysis
- Tablets
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.